All In Biotech

Free tool

FAERS Monitor: Rituxan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103705 or its brand name (Rituxan, Rituximab). Reports on generic versions are filed under their own applications.

Reports

214,105

Serious

191,594

89% of reports

Hospitalization

69,231

Death reported

37,921

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use41,722
  • drug ineffective34,408
  • rheumatoid arthritis20,327
  • pain17,935
  • fatigue17,483
  • rash13,683
  • arthralgia13,466
  • pneumonia13,256
  • infusion related reaction12,870
  • drug intolerance12,675
  • joint swelling12,000
  • pyrexia11,912
  • nausea11,843
  • infection11,292
  • alopecia10,955

Reports by year received

View as table
YearReports
2004508
2005739
2006724
20071,256
20081,417
20092,038
20102,486
20113,186
20124,694
20134,805
20145,019
20155,951
20166,768
201711,206
201812,326
201914,980
202020,539
202118,597
202221,328
202320,221
202424,171
202518,885
202612,260

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,840,054 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal12,87023.423.0223,360
rheumatoid arthritisSignal20,32721.220.9323,022
drug intoleranceSignal12,67514.714.4141,070
joint swellingSignal12,00010.710.595,931
infectionSignal11,2928.28.166,558
alopeciaSignal10,9555.75.640,912
off label useSignal41,7224.94.8127,296
pneumoniaSignal13,2564.24.130,883
pyrexiaSignal11,9123.53.420,524
arthralgiaSignal13,4663.33.220,759
rashSignal13,6833.23.119,873
painSignal17,9352.92.922,710
drug ineffectiveSignal34,4082.62.635,401
fatigueSignal17,4832.22.212,091
nausea11,8431.51.51,868

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.